GPC5 and lymphoma: It is noted that the amplification involves MIR17HG and the breakpoint is located within GPC5, resulting in partial amplification of GPC5. Amplification at 13q31-32 has been reported in lymphoma, indicating that GPC522 and C13orf2523 correspond to MIR17HG as the targets.